TORONTO and SMITHS FALLS, ON, Aug. 8, 2018 /CNW/ – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth” or the “Company”) and its wholly owned subsidiary, Canopy Health Innovations Inc. (“Canopy Health” or “CHI”) is pleased to announce that approval has been received from the Veterinary Drug Directorate of Health Canada to research the effectiveness […]

by

Focus remains on advancing pipeline across cannabinoid and spray platforms PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids (CBD) and spray technology, today reported financial results for its second quarter ended June 30, 2018. OVERALL HIGHLIGHTS Reached agreement in principle […]

by

In recent years, we have seen some extraordinary results related to the use of CBD for treatment and therapy in a variety of different health conditions. However, there is one particular condition that perhaps sits atop the pyramid as far as the sense of dramatic relief related to CBD use:  Dravet Syndrome. Understanding Dravet Syndrome […]

by

One of the major ingredients of the cannabis plant might help extend the lives of patients with pancreatic cancer undergoing chemotherapy, according to new research.   Scientists from Queen Mary University in London found mice undergoing chemotherapy for the disease survived almost three times longer if they received cannabis extract cannabidiol (CBD) as well. Lead researcher Professor Marco […]

by

The marijuana market is already worth billions of dollars, and it’s expected to grow even more as marijuana momentum accelerates. Will cannabis become legal worldwide? And, if it does, will medical marijuana companies like GW Pharmaceuticals (NASDAQ:GWPH) or diversified marijuana companies like Canopy Growth (NYSE:CGC) be the best way to profit from it? In this episode of The Motley […]

by

In recent years, we have seen some extraordinary results related to the use of CBD for treatment and therapy in a variety of different health conditions. However, there is one particular condition that perhaps sits atop the pyramid as far as the sense of dramatic relief related to CBD use:  Dravet Syndrome. Understanding Dravet Syndrome […]

by

The marijuana market is already worth billions of dollars, and it’s expected to grow even more as marijuana momentum accelerates. Will cannabis become legal worldwide? And, if it does, will medical marijuana companies like GW Pharmaceuticals (NASDAQ:GWPH) or diversified marijuana companies like Canopy Growth (NYSE:CGC) be the best way to profit from it? In this episode of The Motley […]

by

<!– Trending Stock News –> August 6, 2018 – By Joe Cepeda Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) had an increase of 29.94% in short interest. NVIV’s SI was 315,100 shares in August as released by FINRA. Its up 29.94% from 242,500 shares previously. With 329,200 avg volume, 1 days are for Invivo Therapeutics Holdings Corp […]

by

Opdivo, Yervoy Combination For Colorectal Cancer Cases The combination of nivolumab (Opdivo) and ipilimumab (Yervoy), both made by Bristol-Myers Squibb, has received FDA accelerated approval for the treatment of adult and pediatric patients 12 years of age and older with microsatellite instability high or mismatch repair deficient metastatic colorectal cancer (mCRC) that has progressed following […]

by

Opdivo, Yervoy Combination For Colorectal Cancer Cases The combination of nivolumab (Opdivo) and ipilimumab (Yervoy), both made by Bristol-Myers Squibb, has received FDA accelerated approval for the treatment of adult and pediatric patients 12 years of age and older with microsatellite instability high or mismatch repair deficient metastatic colorectal cancer (mCRC) that has progressed following […]

by